BMJ
- ROSKVIST R, Eggleton K, Arroll B, Stewart R, et al
Non-acute heart failure management in primary care.
BMJ. 2024;385:e077057.
Cardiovasc Res
- KASS DA
Benchmarking pre-clinical heart failure with preserved ejection fraction models:
can we do better?
Cardiovasc Res. 2024 Apr 4:cvae059. doi: 10.1093.
Circ Cardiovasc Qual Outcomes
- GOUDA P, Rathwell S, Colin-Ramirez E, Felker GM, et al
Utilizing Quality of Life Adjusted Days Alive and Out of Hospital in Heart
Failure Clinical Trials.
Circ Cardiovasc Qual Outcomes. 2024 Apr 3:e010560.
Circ Heart Fail
- WAHID M, Islam S, Sepehrvand N, Dover DC, et al
Iron Deficiency, Anemia, and Iron Supplementation in Patients With Heart Failure:
A Population-Level Study.
Circ Heart Fail. 2024 Apr 4:e011351. doi: 10.1161/CIRCHEARTFAILURE.123.011351.
- MARTENS P, Tang WHW
Defining Iron Deficiency in Heart Failure: Importance of Transferrin Saturation.
Circ Heart Fail. 2024 Apr 3:e011440. doi: 10.1161/CIRCHEARTFAILURE.123.011440.
Circulation
- KAPELIOS CJ, Lund LH
Preemptive Versus Urgent Heart Failure Hospitalization as a Surrogate for
Mortality Risk in Heart Failure.
Circulation. 2024;149:1062-1064.
- GOKULNATH P, Spanos M, Lehmann HI, Sheng Q, et al
Distinct Plasma Extracellular Vesicle Transcriptomes in Acute Decompensated Heart
Failure Subtypes: A Liquid Biopsy Approach.
Circulation. 2024;149:1147-1149.
-
Correction to: INO80-Dependent Remodeling of Transcriptional Regulatory Network
Underlies the Progression of Heart Failure.
Circulation. 2024;149:e1066.
- BREATHETT K, Lewsey S, Brownell NK, Enright K, et al
Implementation Science to Achieve Equity in Heart Failure Care: A Scientific
Statement From the American Heart Association.
Circulation. 2024 Apr 3. doi: 10.1161/CIR.0000000000001231.
Eur Heart J
- ALCOCER-GAMBA MA, Alvarez-Sangabriel A, de la Parra-Calderon JA
Management of heart failure in Mexico: challenges and opportunities.
Eur Heart J. 2024 Mar 29:ehae059. doi: 10.1093.
Eur J Heart Fail
- RAO VS, Ivey-Miranda JB, Cox ZL, Moreno-Villagomez J, et al
Serial direct sodium removal in patients with heart failure and diuretic
resistance.
Eur J Heart Fail. 2024 Mar 31. doi: 10.1002/ejhf.3196.
- MARTENS P, Greene SJ, Mentz RJ, Li S, et al
Impact of baseline kidney dysfunction on oral diuretic efficacy following
hospitalization for heart failure - insights from TRANSFORM-HF.
Eur J Heart Fail. 2024 Apr 1. doi: 10.1002/ejhf.3207.
- MOKRI H, Clephas PRD, de Boer RA, van Baal P, et al
Cost-effectiveness of remote haemodynamic monitoring by an implantable pulmonary
artery pressure monitoring sensor (CardioMEMS-HF system) in chronic heart failure
in the Netherlands.
Eur J Heart Fail. 2024 Apr 1. doi: 10.1002/ejhf.3213.
- RODES-CABAU J, Lindenfeld J, Abraham WT, Zile MR, et al
Interatrial shunt therapy in advanced heart failure: Outcomes from the open-label
cohort of the RELIEVE-HF trial.
Eur J Heart Fail. 2024 Apr 1. doi: 10.1002/ejhf.3215.
- MORILLAS H, Nunez J, Moliner P
Circulating levels of carbohydrate antigen 125 in chronic heart failure: Useful
or futile?
Eur J Heart Fail. 2024 Apr 1. doi: 10.1002/ejhf.3212.
- TROMP J, Kosiborod MN, Angermann CE, Collins SP, et al
Treatment effects of empagliflozin in hospitalized heart failure patients across
the range of left ventricular ejection fraction - Results from the EMPULSE trial.
Eur J Heart Fail. 2024 Apr 4. doi: 10.1002/ejhf.3218.
- LENSELINK C, Ricken KWLM, Groot HE, de Bruijne TJ, et al
Incidence and predictors of heart failure with reduced and preserved ejection
fraction after ST-elevation myocardial infarction in the contemporary era of
early percutaneous coronary intervention.
Eur J Heart Fail. 2024 Apr 4. doi: 10.1002/ejhf.3225.
J Am Coll Cardiol
- COX ZL, Collins SP, Hernandez GA, McRae AT 3rd, et al
Efficacy and Safety of Dapagliflozin in Patients With Acute Heart Failure.
J Am Coll Cardiol. 2024;83:1295-1306.
- COSTANZO MR, Januzzi JL
Early SGLT2 Inhibitors in Acute Heart Failure: Safe Diuretic-Sparing Strategy.
J Am Coll Cardiol. 2024;83:1307-1309.
- ACHANTA A, Belak L, Ritchie CS, Januzzi JL, et al
Age-Related Usage of GLP-1 Agonists in Obese Patients With Heart Failure
and Preserved Ejection Fraction.
J Am Coll Cardiol. 2024;83:1348-1350.
J Card Fail
- KIDA K, Toki S, Kanamitsu Y, Okuno T, et al
Hospice in Heart Failure is Visible, Yet Still Out of Reach for Many.
J Card Fail. 2024 Mar 27:S1071-9164(24)00107.
J Cardiovasc Pharmacol
- POLLESELLO P
Repetitive treatments with inotropes in advanced heart failure.
J Cardiovasc Pharmacol. 2024 Apr 2. doi: 10.1097/FJC.0000000000001569.
-
The Role of SGLT2 Inhibitors on Heart Failure Outcomes in Nondiabetic Patients: A
Systematic Review and Meta-Analysis of Randomized Controlled Trials Erratum.
J Cardiovasc Pharmacol. 2024;83:359.
PLoS One
- MAURY P, Sanchis K, Djouadi K, Cariou E, et al
Catheter ablation of atrial arrhythmias in cardiac amyloidosis: Impact on heart
failure and mortality.
PLoS One. 2024;19:e0301753.
- WIEST C, Philipp A, Foltan M, Geismann F, et al
Refractory circulatory failure in COVID-19 patients treated with veno-arterial
ECMO a retrospective single-center experience.
PLoS One. 2024;19:e0298342.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016